Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?

Richard J Miron, Masako Fujioka-Kobayashi, Maria Hernandez, Umadevi Kandalam, Yufeng Zhang, Shahram Ghanaati, Joseph Choukroun, Richard J Miron, Masako Fujioka-Kobayashi, Maria Hernandez, Umadevi Kandalam, Yufeng Zhang, Shahram Ghanaati, Joseph Choukroun

Abstract

Objectives: Platelet rich plasma (PRP) has been utilized in regenerative dentistry as a supra-physiological concentrate of autologous growth factors capable of stimulating tissue regeneration. Despite this, concerns have been expressed regarding the use of anti-coagulants, agents known to inhibit wound healing. In this study, a liquid formulation of platelet rich fibrin (PRF) termed injectable-PRF (i-PRF) without the use of anti-coagulants was investigated.

Materials and methods: Standard PRP and i-PRF (centrifuged at 700 rpm (60G) for 3 min) were compared for growth factor release up to 10 days (8 donor samples). Furthermore, fibroblast biocompatibility at 24 h (live/dead assay); migration at 24 h; proliferation at 1, 3, and 5 days, and expression of PDGF, TGF-β, and collagen1 at 3 and 7 days were investigated.

Results: Growth factor release demonstrated that in general PRP had higher early release of growth factors whereas i-PRF showed significantly higher levels of total long-term release of PDGF-AA, PDGF-AB, EGF, and IGF-1 after 10 days. PRP showed higher levels of TGF-β1 and VEGF at 10 days. While both formulations exhibited high biocompatibility and higher fibroblast migration and proliferation when compared to control tissue-culture plastic, i-PRF induced significantly highest migration whereas PRP demonstrated significantly highest cellular proliferation. Furthermore, i-PRF showed significantly highest mRNA levels of TGF-β at 7 days, PDGF at 3 days, and collagen1 expression at both 3 and 7 days when compared to PRP.

Conclusions: i-PRF demonstrated the ability to release higher concentrations of various growth factors and induced higher fibroblast migration and expression of PDGF, TGF-β, and collagen1. Future animal research is now necessary to further validate the use of i-PRF as a bioactive agent capable of stimulating tissue regeneration.

Clinical relevance: The findings from the present study demonstrate that a potent formulation of liquid platelet concentrates could be obtained without use of anti-coagulants.

Keywords: Blood platelets; Fibrin; Fibroblasts; Platelet rich fibrin; Regeneration; Wound healing.

References

    1. J Indian Soc Periodontol. 2014 May;18(3):399-402
    1. Clin Implant Dent Relat Res. 2014 Feb;16(1):1-20
    1. Am J Clin Dermatol. 2016 Aug;17 (4):359-67
    1. Clin Oral Implants Res. 2012 Feb;23 Suppl 5:1-21
    1. Biomed Res Int. 2015;2015:846045
    1. J Conserv Dent. 2013 May;16(3):261-4
    1. J Periodontol. 2017 Jan;88(1):112-121
    1. Clin Oral Investig. 2016 Dec;20(9):2353-2360
    1. J Clin Periodontol. 2014 Sep;41(9):914-26
    1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun;85(6):638-46
    1. Int J Oral Maxillofac Implants. 1999 Jul-Aug;14(4):529-35
    1. Compend Contin Educ Dent. 2014 Mar;35(3):192-8
    1. J Indian Soc Periodontol. 2009 Jan;13(1):50-4
    1. Wound Repair Regen. 1999 Nov-Dec;7(6):410-22
    1. J Oral Implantol. 2014 Dec;40(6):679-89
    1. J Craniofac Surg. 2013 Jul;24(4):1088-94
    1. Tissue Eng Part B Rev. 2017 Feb;23 (1):83-99
    1. J Int Oral Health. 2015 Apr;7(4):32-7
    1. Musculoskeletal Care. 2016 Jun;14 (2):121-5
    1. J Investig Clin Dent. 2016 Feb;7(1):13-26
    1. J Periodontal Res. 2012 Aug;47(4):409-17
    1. J Periodontol. 2016 Feb;87(2):103-13
    1. Immun Ageing. 2013 Jun 13;10(1):23
    1. Prostaglandins Leukot Essent Fatty Acids. 1989 Apr;36(1):1-7
    1. Platelets. 2016 Jul;27(5):459-66
    1. Arthroscopy. 2016 Mar;32(3):495-505
    1. Transfusion. 1990 Sep;30(7):634-8
    1. J Shoulder Elbow Surg. 2015 Dec;24(12 ):1852-9
    1. Int J Periodontics Restorative Dent. 2012 Apr;32(2):e41-50
    1. Thromb Haemost. 1982 Dec 27;48(3):260-2
    1. J Periodontal Res. 2016 Aug;51(4):481-8
    1. BMC Musculoskelet Disord. 2010 Apr 14;11:69
    1. J Oral Implantol. 2011 Dec;37(6):681-90
    1. Thromb Res. 1983 Jan 15;29(2):243-8
    1. Int J Dent. 2013;2013:875380
    1. Contemp Clin Dent. 2012 Sep;3(Suppl 2):S240-3
    1. J Evid Based Dent Pract. 2012 Sep;12(3 Suppl):149-60
    1. Curr Pharm Biotechnol. 2012 Jun;13(7):1153-62
    1. Science. 1997 Apr 4;276(5309):75-81
    1. J Med Case Rep. 2015 Nov 02;9:252
    1. J Maxillofac Oral Surg. 2015 Jun;14(2):410-6
    1. J Periodontol. 2012 Jul;83(7):936-47

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi